AIM
ABBV icon

Anchor Investment Management’s AbbVie ABBV Stock Holding History

Anchor Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Buy
87,821
+618
+0.7% +$137K 1.59% 13
2025
Q4 		$19.9M Buy
87,203
+2,542
+3% +$579K 1.62% 12
2025
Q3 		$19.6M Sell
84,661
-617
-0.7% -$126K 1.62% 13
2025
Q2 		$15.8M Buy
85,278
+352
+0.4% +$65.4K 1.39% 14
2025
Q1 		$17.8M Sell
84,926
-5,805
-6% -$1.13M 1.66% 10
2024
Q4 		$16.1M Buy
90,731
+2,015
+2% +$370K 1.5% 14
2024
Q3 		$17.5M Buy
88,716
+2,527
+3% +$472K 1.65% 9
2024
Q2 		$14.8M Buy
86,189
+691
+0.8% +$114K 1.52% 13
2024
Q1 		$15.6M Sell
85,498
-2,809
-3% -$484K 1.63% 9
2023
Q4 		$13.7M Buy
88,307
+4,660
+6% +$679K 1.57% 9
2023
Q3 		$12.5M Buy
83,647
+61
+0.1% +$8.96K 1.63% 9
2023
Q2 		$11.3M Buy
83,586
+3,623
+5% +$531K 1.44% 10
2023
Q1 		$12.7M Buy
79,963
+1,329
+2% +$203K 1.74% 5
2022
Q4 		$12.7M Buy
78,634
+181
+0.2% +$27.8K 1.82% 5
2022
Q3 		$10.5M Sell
78,453
-3,011
-4% -$432K 1.63% 7
2022
Q2 		$12.5M Buy
81,464
+787
+1% +$120K 1.81% 4
2022
Q1 		$13.1M Buy
80,677
+4,185
+5% +$608K 1.65% 7
2021
Q4 		$10.4M Sell
76,492
-1,066
-1% -$126K 1.29% 12
2021
Q3 		$8.37M Buy
77,558
+1,381
+2% +$158K 1.16% 13
2021
Q2 		$8.58M Buy
76,177
+1,806
+2% +$203K 1.19% 13
2021
Q1 		$8.05M Buy
74,371
+10,100
+16% +$1.08M 1.23% 12
2020
Q4 		$6.89M Buy
64,271
+10,911
+20% +$1.05M 1.24% 13
2020
Q3 		$4.67M Buy
53,360
+4,407
+9% +$415K 0.95% 23
2020
Q2 		$4.81M Buy
48,953
+2,422
+5% +$213K 1.08% 15
2020
Q1 		$3.55M Buy
46,531
+3,210
+7% +$273K 0.91% 23
2019
Q4 		$3.84M Buy
43,321
+1,194
+3% +$99.1K 0.82% 28
2019
Q3 		$3.19M Buy
42,127
+1,954
+5% +$134K 0.73% 31
2019
Q2 		$2.92M Sell
40,173
-1,030
-2% -$81K 0.7% 35
2019
Q1 		$3.32M Sell
41,203
-5,365
-12% -$439K 0.83% 29
2018
Q4 		$4.29M Buy
46,568
+73
+0.2% +$6.42K 1.22% 12
2018
Q3 		$4.4M Sell
46,495
-851
-2% -$80.7K 1.01% 16
2018
Q2 		$4.39M Buy
47,346
+1,639
+4% +$160K 1.08% 14
2018
Q1 		$4.33M Sell
45,707
-594
-1% -$65.3K 1.13% 14
2017
Q4 		$4.48M Sell
46,301
-699
-1% -$65.9K 1.19% 11
2017
Q3 		$4.18M Buy
47,000
+1,394
+3% +$106K 1.22% 11
2017
Q2 		$3.31M Buy
45,606
+785
+2% +$52.8K 1.1% 17
2017
Q1 		$2.92M Buy
44,821
+308
+0.7% +$19.4K 1% 20
2016
Q4 		$2.79M Sell
44,513
-278
-0.6% -$17K 1.04% 19
2016
Q3 		$2.82M Buy
44,791
+248
+0.6% +$16.1K 1.1% 17
2016
Q2 		$2.76M Buy
44,543
+607
+1% +$37K 1.09% 15
2016
Q1 		$2.51M Buy
+43,936
New +$2.45M 1.03% 21

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Anchor Investment Management's ABBV Position: Q1 2026 in Review

Anchor Investment Management increased its AbbVie (ABBV) stake by 0.71% in Q1 2026, buying an estimated $137K and bringing the position to 87,821 shares worth $19.1M. The position accounts for 1.59% of the portfolio, ranked #13.

Anchor Investment Management first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $19.9M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Anchor Investment Management held 87,821 shares of AbbVie worth $19.1M as of Q1 2026.
  • Anchor Investment Management bought 618 AbbVie shares in Q1 2026, an estimated $137K.
  • AbbVie made up 1.59% of Anchor Investment Management's portfolio in Q1 2026, its #13 holding.
  • Anchor Investment Management first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's AbbVie position peaked at $19.9M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.